Drug Shortage Report for TARO-CEFPROZIL
Report ID | 175062 |
Drug Identification Number | 02293528 |
Brand name | TARO-CEFPROZIL |
Common or Proper name | CEFPROZIL |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | CEFPROZIL |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | J01DC |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-10-20 |
Estimated end date | 2023-01-27 |
Actual end date | 2022-12-21 |
Shortage status | Resolved |
Updated date | 2023-02-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-02-01 | French | Compare |
v9 | 2023-02-01 | English | Compare |
v8 | 2022-12-12 | French | Compare |
v7 | 2022-12-12 | English | Compare |
v6 | 2022-12-12 | French | Compare |
v5 | 2022-12-12 | English | Compare |
v4 | 2022-11-25 | French | Compare |
v3 | 2022-11-25 | English | Compare |
v2 | 2022-11-16 | French | Compare |
v1 | 2022-11-16 | English | Compare |
Showing 1 to 10 of 10